AbbVie Inc. (ABBV) vs Pfizer Inc. (PFE)
PFE leads on 8 of 14 compared metrics.
A side-by-side comparison of AbbVie Inc. and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — ABBV vs PFE
growth of $100 · last 14yABBV +544.8%PFE +7.8%ABBV compounded faster
Log scale — wide-divergence pair
ABBV PFE
ABBV vs PFE: by the numbers
- •ABBV is the larger company ($402.35B vs $149.38B market cap).
- •PFE trades at the lower earnings multiple (20.01 vs 111.67 P/E).
- •PFE converts more revenue to profit (11.83% vs 5.79% net margin).
- •PFE grew revenue faster over the past five years (8.22% vs 4.59% CAGR).
- •PFE pays the higher dividend yield (6.56% vs 2.96%).
Which is better, ABBV or PFE?
Metric tally: ABBV 6 · PFE 8It depends on what you're optimizing for:
ValuePFE(lower P/E)
GrowthPFE(faster 5Y revenue CAGR)
IncomePFE(higher dividend yield)
QualityABBV(higher ROIC)
Valuation
| Metric | ABBV | PFE |
|---|---|---|
| P/E ratio | 111.67 | 20.01● |
| Forward P/E | — | 9.25 |
| P/S ratio | 6.43 | 2.37● |
| P/B ratio | 14.69 | 1.67● |
| EV / EBITDA | 27.63 | 12.72● |
| FCF yield | 5.17% | 6.31%● |
Profitability
| Metric | ABBV | PFE |
|---|---|---|
| Gross margin | 70.68% | 69.35% |
| Operating margin | 27.60%● | 23.45% |
| Net margin | 5.79% | 11.83%● |
| ROE | 13.23%● | 8.31% |
| ROIC | 12.97%● | 8.84% |
Dividends
| Metric | ABBV | PFE |
|---|---|---|
| Dividend yield | 2.96% | 6.56%● |
| Payout ratio | 284.39% | 126.47% |
Growth (annualized)
| Metric | ABBV | PFE |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | 8.22%● |
| EPS CAGR (5Y) | -2.79%● | -3.78% |
| FCF CAGR (5Y) | 3.24%● | -3.79% |
| Total return CAGR (5Y) | 18.95%● | -3.33% |
Frequently asked
- Which is better, ABBV or PFE?
- It depends on your goal. value: PFE (lower P/E); growth: PFE (faster 5Y revenue CAGR); income: PFE (higher dividend yield); quality: ABBV (higher ROIC). Across all compared metrics, PFE leads 8 to 6.
- Is ABBV or PFE cheaper?
- On trailing earnings, PFE is cheaper: ABBV trades at a 111.67 P/E and PFE at 20.01.
- Which has grown faster, ABBV or PFE?
- Over the past five years, PFE grew revenue faster — ABBV at a 4.59% CAGR versus PFE at 8.22%.
- Does ABBV or PFE pay a bigger dividend?
- ABBV yields 2.96% and PFE yields 6.56% based on trailing dividends and the latest price.
- Is ABBV or PFE more profitable?
- PFE runs the higher net margin — ABBV at 5.79% versus PFE at 11.83%.
- Which has been the better investment, ABBV or PFE?
- Over the past 10-year, ABBV delivered the higher annualized total return — ABBV at 18.88% versus PFE at 2.13%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioPfizer P/E ratioAbbVie dividend yieldPfizer dividend yieldAbbVie ROEPfizer ROEAbbVie operating marginPfizer operating marginAbbVie revenue growthPfizer revenue growthAbbVie free cash flowPfizer free cash flow
AbbVie & Pfizer appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.